The first non-invasive screening device for infant meningitis
It’s born

put

The Neosonics is a sophisticated precision-engineering system using high-frequency ultrasound to non-invasively count white blood cell in the cerebrospinal fluid below the infant fontanel, the region of the head where the bones are not yet closed.
In the current practice, increased cerebrospinal fluid white blood cell count obtained through lumbar puncture immediately triggers medication irrespective of diagnostic bacteriologic results.

You will think it’s always been there

put

Place

Place the Neosonics on the infant fontanel, the head area where bones are not yet closed

Push

Push the button to get the cerebrospinal fluid (CSF) white blood cell (WBC) count

Detect

Detect abnormal CSF WBC count to immediately trigger medication or to follow-up patient’s response to treatment

WHAT MAKES NEOSONICS UNIQUE IN ITS KIND?

  • Non-invasive
  • Treatment monitoring
  • Easy to use
  • Real time
  • Cost-effective

THE NEW STANDARD FOR SCREENING AND TREATMENT MONITORING

ACCOMPLISHMENTS

put

SENSITIVITY TO ANY CELL CONCENTRATION

put

FEASIBILITY ON
PATIENTS

put

100% ACCEPTANCE MARKET STUDY

put

WILLINGNESS TO PAY FROM FUTURE CUSTOMERS

THE NEW STANDARD FOR SCREENING AND TREATMENT MONITORING

Neosonics will revolutionize the management and diagnosis of infant meningitis by enabling quick, easy detection and quantitative, reliable and frequent treatment monitoring.

WE WANT TO KNOW ABOUT YOU

Have you or your loved ones experienced a serious infection? We exist to help people having a better healthcare, that is why your testimonial is so important to us. Share yours with us:

SHARE